Aspartic Proteases in Drug Discovery

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|3|271-285

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.3, 2007-01, pp. : 271-285

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

On the Active Site Protonation State in Aspartic Proteases: Implications for Drug Design

By  

Current Pharmaceutical Design, Vol. 19, Iss. 23, 2013-07 ,pp. : 4257-4275

Bentham Science Publishers

Access to resources Recommend Favorite

Antiviral Drug Discovery Targeting to Viral Proteases

By  

Current Pharmaceutical Design, Vol. 12, Iss. 11, 2006-04 ,pp. : 1301-1314

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of aspartic proteases – potential antimalarial agents

By Boss Christoph   Corminboeuf Olivier   Grisostomi Corinna   Weller Thomas  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 3, 2006-03 ,pp. : 295-317

Informa Healthcare

Access to resources Recommend Favorite

Targeting Cysteine Proteases from Plasmodium falciparum: A General Overview, Rational Drug Design and Computational Approaches for Drug Discovery

By  

Current Drug Targets, Vol. 19, Iss. 5, 2018-03 ,pp. : 501-526

Bentham Science Publishers

Access to resources Recommend Favorite

Activity Based Probes for Proteases: Applications to Biomarker Discovery,Molecular Imaging and Drug Screening

By  

Current Pharmaceutical Design, Vol. 13, Iss. 3, 2007-01 ,pp. : 253-261

Bentham Science Publishers

Access to resources Recommend Favorite